An internally and externally validated nomogram for predicting cancer- specific survival in octogenarians after radical resection for colorectal cancer

Author:

Zhu Junchang1,Cen Wei1,Zheng Xuzhi1,Ye Chenqiao1,Guo Feifan1,Yan Xialin1,Shi Hongying2,Ye Lechi1,Hu Tingting1

Affiliation:

1. First Affiliated Hospital of Wenzhou Medical University

2. Wenzhou Medical University

Abstract

Abstract Purpose We aimed to develop an elaborative nomogram that predicts cancer-specific survival (CSS) in American and Chinese octogenarians treated with radical resection for CRC. Method The patient data of newly diagnosed patients aged 80 years or older who underwent radical resection for CRC from 2010 to 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database and then randomly divided into a training cohort and a validation cohort. The patients collected from our hospital were defined as the external validation cohort. Univariate and multivariate Cox regression was used to select independent predictive factors for the construction of a nomogram to predict 1-, 2- and 3-year CSS. Results The multivariate Cox regression model identified age, T stage, N stage, perineural invasion, chemotherapy, tumour deposits, carcinoembryonic antigen level, number of lymph node metastases, and number of solid organ metastases as independent predictors of survival. The C-index of the nomogram for 1-, 2- and 3-year CSS was 0.758, 0.762, and 0.727, respectively, demonstrating significant clinical value and substantial reliability compared to the TNM stage. The calibration curve and area under the curve also indicated considerable predictive accuracy. In addition, decision curve analysis demonstrated desirable net benefits in clinical application. Conclusion We constructed a nomogram for predicting the CSS of individual octogenarian patients with CRC who underwent radical resection. The nomogram performed better than the TNM staging system in this particular population and could guide clinicians in clinical follow-up and individual therapeutic plan formulation.

Publisher

Research Square Platform LLC

Reference42 articles.

1. Cancer Registry and Statistics. (Monitoring of Cancer Incidence in Japan (MCIJ)). Cancer Information Service, National Cancer Center, Japan. Available at: https://ganjoho.jp/reg_stat/statistics/dl/index.html. Accessed 19 December 2022. In Japanese.

2. European Commission B Population Structure and Ageing. [(accessed on 19 December 2022)]; Available online: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageing.

3. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Plus Data, 12 Registries, Nov 2021 Sub (1992–2019) - Linked To County Attributes - Time Dependent (1990–2019) Income/Rurality, 1969–2020 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2022, based on the November 2021 submission.

4. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging;Amin MB;CA Cancer J Clin,2017

5. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Benson AB;J Natl Compr Canc Netw,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3